Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2018 · 10-Q
Revenue$210.95M$210.95M+0.5% vs Q1 2017 Net Income$20.14M$20.14MN/M vs Q1 2017 EPS Diluted$0.38$0.38N/M vs Q1 2017 Gross Profit$91,665,000+0.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$38,425,000+25.2% Free Cash Flowderived$24,704,000+200.7% Margins · derivedGross margin43.5%+0.1 pt vs Q1 2017
Operating margin7.9%+11.6 pt vs Q1 2017
Net margin9.5%+14.5 pt vs Q1 2017
ended Jul 1, 2017 · filed Aug 7, 2017 · 37 d after period end